We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




BD Completes Acquisition of Critical Care from Edwards Lifesciences

By HospiMedica International staff writers
Posted on 04 Sep 2024
Print article
Image: Edwards Lifesciences’ Critical Care product group will be renamed as BD Advanced Patient Monitoring (Photo courtesy of BD)
Image: Edwards Lifesciences’ Critical Care product group will be renamed as BD Advanced Patient Monitoring (Photo courtesy of BD)

BD (Becton, Dickinson and Company, Franklin Lakes, J, USA) has completed the acquisition of Edwards Lifesciences' (Irvine, CA, USA) Critical Care product group, which will be renamed as BD Advanced Patient Monitoring.

BD Advanced Patient Monitoring offers advanced monitoring solutions that expand BD's portfolio of smart connected care solutions with its growing set of leading monitoring technologies and advanced AI-enabled clinical decision tools. BD Advanced Patient Monitoring's technologies are often used alongside the BD Alaris Infusion System in the OR and ICU. The combination of BD's new advanced monitoring and existing infusion platforms enables future innovation opportunities for closed-loop hemodynamic monitoring and IV fluid and medication administration by integrating combined company data sets and interoperability capabilities.

BD Advanced Patient Monitoring's portfolio comprises the gold-standard Swan Ganz pulmonary artery catheter, minimally invasive sensors, noninvasive cuffs, tissue oximetry sensors, and monitors. Its smart technologies are driven by advanced data analytics with machine learning and AI-based predictive and prescriptive algorithms to help clinicians better understand current and future patient conditions and provide clinical decision support tools. BD Advanced Patient Monitoring will operate as a separate business unit within BD's Medical segment in line with its smart connected care approach.

"The healthcare industry is being redefined by AI, robotics, and autonomous solutions, and our team continues to accelerate the application of these new technologies to improve the quality and cost of patient care around the world," said Tom Polen, chairman, chief executive officer and president of BD. "Today, BD is proud to welcome BD Advanced Patient Monitoring, whose leading technologies, AI-enabled solutions, and strong innovation pipeline expand our portfolio of smart, connected care solutions, create significant value for customers, and put BD at the forefront of enabling the future of health care."

 

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Bone Marrow Biopsy Needle
BEST-LISAS
New
Pediatric Stretcher
PS410

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.